Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Enhancing Tregs can protect against alopecia areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.